Xvivo Perfusion AB 

€0
0
+€0+0% 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

其他人也在關注

此清單是根據在 Stock Events 上追蹤 3XV.MU 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Show more...
執行長
Mr. Christoffer Rosenblad
員工
193
國家
美國
ISIN
SE0004840718

上市

0 Comments

分享你的想法

FAQ

Xvivo Perfusion AB 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Xvivo Perfusion AB 的股票以代號 3XV.MU 進行交易。
Xvivo Perfusion AB 有多少名員工?
截至 April 12, 2026,公司共有 193 名員工。
Xvivo Perfusion AB 位於哪個產業?
Xvivo Perfusion AB從事於Health & Wellness產業。
Xvivo Perfusion AB 何時完成拆股?
Xvivo Perfusion AB 最近沒有進行任何拆股。
Xvivo Perfusion AB 的總部在哪裡?
Xvivo Perfusion AB 的總部位於 美國 的 Mölndal。